209 related articles for article (PubMed ID: 18192010)
1. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.
Ghoshal Gupta S; Baumann H; Wetzler M
Leuk Res; 2008 Jul; 32(7):1005-14. PubMed ID: 18192010
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells.
Zhao J; Xu Y; Zong Y; Zhang S; Song Y; Yu K; Li Z; Ji Y; Qiu Y; Chen F
Hematology; 2011 Jul; 16(4):232-5. PubMed ID: 21756540
[TBL] [Abstract][Full Text] [Related]
3. STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.
Bruserud Ø; Nepstad I; Hauge M; Hatfield KJ; Reikvam H
Expert Rev Hematol; 2015 Feb; 8(1):29-41. PubMed ID: 25374305
[TBL] [Abstract][Full Text] [Related]
4. β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis.
Oellerich T; Oellerich MF; Engelke M; Münch S; Mohr S; Nimz M; Hsiao HH; Corso J; Zhang J; Bohnenberger H; Berg T; Rieger MA; Wienands J; Bug G; Brandts C; Urlaub H; Serve H
Blood; 2013 May; 121(19):3889-99, S1-66. PubMed ID: 23509157
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.
Benekli M; Xia Z; Donohue KA; Ford LA; Pixley LA; Baer MR; Baumann H; Wetzler M
Blood; 2002 Jan; 99(1):252-7. PubMed ID: 11756179
[TBL] [Abstract][Full Text] [Related]
6. Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia.
Zhou J; Chong PS; Lu X; Cheong LL; Bi C; Liu SC; Zhou Y; Tan TZ; Yang H; Chung TH; Zeng Q; Chng WJ
Exp Hematol; 2014 Dec; 42(12):1041-52.e1-2. PubMed ID: 25139404
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
8. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
Steensma DP; McClure RF; Karp JE; Tefferi A; Lasho TL; Powell HL; DeWald GW; Kaufmann SH
Leukemia; 2006 Jun; 20(6):971-8. PubMed ID: 16598306
[TBL] [Abstract][Full Text] [Related]
9. Targeting signal transducer and activator of transcription signaling pathway in leukemias.
Benekli M; Baumann H; Wetzler M
J Clin Oncol; 2009 Sep; 27(26):4422-32. PubMed ID: 19667270
[TBL] [Abstract][Full Text] [Related]
10. miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling.
Sha C; Jia G; Jingjing Z; Yapeng H; Zhi L; Guanghui X
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):177-187. PubMed ID: 32472154
[TBL] [Abstract][Full Text] [Related]
11. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.
Xia Z; Baer MR; Block AW; Baumann H; Wetzler M
Cancer Res; 1998 Jul; 58(14):3173-80. PubMed ID: 9679986
[TBL] [Abstract][Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.
Brady MT; Miller A; Sait SN; Ford LA; Minderman H; Wang ES; Lee KP; Baumann H; Wetzler M
Leuk Res; 2013 Jul; 37(7):822-8. PubMed ID: 23628554
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
Zhao W; Zhang T; Qu B; Wu X; Zhu X; Meng F; Gu Y; Shu Y; Shen Y; Sun Y; Xu Q
Anticancer Drugs; 2011 Jan; 22(1):79-88. PubMed ID: 20881478
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review).
Song G; Wang L; Bi K; Jiang G
Oncol Rep; 2015 May; 33(5):2099-106. PubMed ID: 25760953
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in AML.
Melnick AM
Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
[TBL] [Abstract][Full Text] [Related]
20. New strategies for relapsed acute myeloid leukemia: fertile ground for translational research.
Dinner SN; Giles FJ; Altman JK
Curr Opin Hematol; 2014 Mar; 21(2):79-86. PubMed ID: 24419335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
